T1	Participants 103 118	southwest China
T2	Participants 248 289	Osteoporosis (OP) and osteoarthritis (OA)
T3	Participants 961 1025	PMO patients (postmenopausal women; aged between 50 and 70 years
T4	Participants 1409 1411	50
T5	Participants 1671 1691	postmenopausal women
